Ekso Bionics® to Report Third Quarter 2017 Financial Results on November 8, 2017
November 01 2017 - 08:00AM
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), an industry leader in
exoskeleton technology for medical and industrial use, today
announced that it will release financial and business results for
the third quarter 2017 after the close of trading on Wednesday,
November 8, 2017. Management will host a conference call
beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial
results and recent business developments.
Investors interested in listening to the
conference call may do so by dialing (877) 407-3036 for domestic
callers or (201) 378-4919 for international callers, using
Conference ID: 13581989. A live webcast of the event will be
available in the “Investors” section of the company’s website at
www.eksobionics.com, or by clicking here.
A replay of the call will be available for two
weeks by dialing (877) 660-6853 for domestic callers or (201)
612-7415 for international callers and using Conference ID:
13581989. The webcast will also be available on the company’s
website for one month following the completion of the call.
About Ekso Bionics®Ekso Bionics
is a leading developer of exoskeleton solutions that amplify human
potential by supporting or enhancing strength, endurance and
mobility across medical, industrial and defense applications.
Founded in 2005, the company continues to build upon its
unparalleled expertise to design some of the most cutting-edge,
innovative wearable robots available on the market. Ekso Bionics is
the only exoskeleton company to offer technologies that range from
helping those with paralysis to stand up and walk, to enhancing
human capabilities on job sites across the globe, to providing
research for the advancement of R&D projects intended to
benefit U.S. defense capabilities. The company is headquartered in
the Bay Area and is listed on the Nasdaq Capital Market under the
symbol EKSO. For more information, visit: www.eksobionics.com.
Media Contact:Carrie
Yamond917-371-2320cyamond@lazarpartners.com
Investor Contact:Matthew
Ventimiglia212-599-1265investors@eksobionics.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2023 to Mar 2024